Evive, Acrotech get FDA nod for Ryzneuta (Efbemalenograstim alfa Injection) for chemo-induced neutropenia
Express Pharma
NOVEMBER 21, 2023
It helps to enhance the immune function of cancer patients and prevent the side effects of neutropenia caused by chemotherapy. Due to its unique molecular structure, Ryzneuta may possess stronger GCSF receptor activation properties and avoid the potential problem (such as allergic reactions) caused by PEG or Tween-80.
Let's personalize your content